Latest 10-K annual reports

Tamboran Resources Corporation's latest 10-K details significant operational progress in the Beetaloo Basin, alongside substantial financial losses and ongoing capital requirements, raising going concern doubts.

Golden Star Resource Corp., an exploration-stage mining company, reported increased net losses for fiscal year 2025 and continues to face substantial doubt about its ability to continue as a going concern without significant new financing.

Rave Restaurant Group, Inc. reported increased net income and Adjusted EBITDA for fiscal year 2025, driven by Pizza Inn's growth despite a decline in Pie Five units and overall revenue.

Upexi, Inc. reported a significant net loss for fiscal year 2025 while strategically shifting its core business to a Solana-focused digital asset treasury and consumer product brand ownership.

THOR Industries reports a 4.6% net sales decrease in fiscal 2025, driven by softening demand in North American Motorized and European segments, alongside strategic operational adjustments and a new share repurchase authorization.

Uranium Energy Corp. significantly expanded its operational footprint and advanced key projects in Fiscal 2025, despite reporting a net loss amidst volatile uranium prices.

Nutanix, a hybrid multicloud computing leader, reported strong fiscal year 2025 results, achieving GAAP net income and significant growth in subscription revenue and free cash flow.

Nexalin Technology, Inc. filed an amendment to its annual report, correcting internal control disclosures and refiling financials that show increased revenue but also widening net losses and persistent going concern doubts.

Palatin Technologies reported a $17.3 million net loss for fiscal year 2025, faces delisting from NYSE American, but secured a significant collaboration with Boehringer Ingelheim and advanced multiple drug candidates.

Natural Alternatives International, Inc. reported a net loss of $13.575 million for fiscal year 2025 despite a 14% increase in net sales, driven by increased operational costs, a litigation settlement, and a significant deferred tax asset valuation allowance.

Aytu BioPharma licenses EXXUA for MDD and raises $16.6M to support commercialization.

Integrated BioPharma, Inc. reported an 8% increase in net sales and a significant rise in net income for the fiscal year ended June 30, 2025, driven by growth in both Contract Manufacturing and Other Business Lines segments.

InMed Pharmaceuticals Inc. reported its fiscal year 2025 results, highlighting progress in its Alzheimer's and dry AMD drug candidates, alongside revenue growth in its BayMedica segment, despite ongoing operating losses and a going concern doubt.

FONAR Corporation reported a decrease in net income for fiscal year 2025 to $10.7 million from $14.1 million in fiscal 2024, driven by higher operating costs and a significant credit loss reserve.

Benitec Biopharma Inc. restated prior period financial statements due to share-based compensation errors, while continuing to advance its lead OPMD gene therapy, BB-301, through clinical trials.

Cannabis Bioscience International Holdings, Inc. reported a reduced net loss for fiscal year 2025, driven by increased clinical trial revenue, while facing significant going concern doubts and a need for substantial capital.

GivBux Inc. reports significant revenue growth in 2024 driven by its Super App, but faces substantial net losses and a going concern doubt, highlighting critical funding needs.

HNO International, Inc. filed an amended annual report to correct service stock valuations, revealing increased stock-based compensation and a higher net loss for fiscal year 2024.

The Marygold Companies, Inc. reported an increased net loss of $5.8 million for fiscal year 2025, driven by reduced revenue in fund management and food products, despite decreased operating expenses.

B. Riley Financial reports a significant net loss of $774.9 million for 2024, driven by investment impairments, while actively reducing its total indebtedness through strategic asset dispositions.

Research Solutions, Inc. reported a significant turnaround in fiscal year 2025, achieving a net income of $1.27 million compared to a $3.79 million net loss in the prior year, driven by robust platform revenue growth.

NAPC Defense, Inc. filed an amended annual report revealing substantial net losses, a significant working capital deficit, and auditor concerns about its ability to continue as a going concern for the fiscal year ended April 30, 2025.

GenFlat Holdings, an early-stage collapsible marine container company, reported a substantial net loss of $4.7 million for fiscal year 2025, raising significant doubt about its ability to continue as a going concern.

Trio-Tech International reported a net loss of $41,000 for fiscal year 2025, a significant decline from the prior year's net income, driven by a 14% decrease in total revenue and unfavorable foreign exchange movements.

American Battery Technology Company (ABTC) reported significant revenue growth in fiscal year 2025, driven by its battery recycling operations, while continuing to advance its lithium extraction projects and secure substantial government grants.

Neolara Corp., a development-stage construction company, reported a 36.9% revenue increase but a 64.8% rise in net loss for fiscal year 2025, alongside significant internal control weaknesses and a going concern warning.

CFSB Bancorp, Inc. reported a net loss of $265,000 for the fiscal year ended June 30, 2025, as it progresses towards a merger with Hometown Financial Group, Inc.

U.S. Global Investors, Inc. filed an amended annual report (10-K/A) to correct the dates on its CEO and CFO certifications for the fiscal year ended June 30, 2025.

Campbell's Company reports a 6% increase in net sales for fiscal year 2025, reaching $10.253 billion, driven by acquisitions and an extra week, while facing significant cost pressures and trademark impairments.

Winchester Bancorp, Inc. reported a net loss of $874,000 for the fiscal year ended June 30, 2025, following its mutual holding company reorganization and initial public offering.